CLINICAL_TRIALS
ClinicalTrials.gov record update
A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Ganciclovir Gel (Zirgan®) Versus 0.3% Hypromellose Gel (Genteal Gel®; Placebo) for the Treatment of Adenovirus Conjunctivitis
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01533480
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:39.938669+00:00
- Published At
- 2018-02-28T00:00:00+00:00
- Record Updated At
- 2018-02-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Keratoconjunctivitis Due to Adenovirus", "Viral Shedding"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-02-28"- protocolSection.identificationModule.nctId
"NCT01533480"- protocolSection.identificationModule.officialTitle
"A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Ganciclovir Gel (Zirgan\u00ae) Versus 0.3% Hypromellose Gel (Genteal Gel\u00ae; Placebo) for the Treatment of Adenovirus Conjunctivitis"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.